QTI Share Price Performance
US$5.49
2.64 (92.63%)
45.1% undervalued intrinsic discount
US$10.00
Fair Value
Price US$5.49
AnalystLowTarget US$10.00
AnalystHighTarget US$13.20
AnalystConsensusTarget US$11.60
Fair ValueUS$10.00
Share Pricen/a
QT Imaging Holdings, Inc. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 14 Fair Values set on narratives written by author
QTI Community Narratives
AN
Fair Value
·Fair Value US$10 45.1% undervalued intrinsic discount
Slow Reimbursement And Costly SaaS Shift Will Ultimately Support Radiation Free Breast Imaging Adoption
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value
·Fair Value US$13.2 58.4% undervalued intrinsic discount
Radiation Free Breast Imaging And Regulatory Progress Will Support Powerful Long Term Upside
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value
·Fair Value US$11.6 52.7% undervalued intrinsic discount
Radiation Free Breast Imaging And Regulatory Momentum Will Support Long Term Screening Adoption
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Radiation Free Breast Imaging And Regulatory Progress Will Support Powerful Long Term Upside
Catalysts About QT Imaging Holdings QT Imaging Holdings develops and commercializes radiation free, compression free 3D breast imaging systems supported by a cloud based software and analytics platform. What are the underlying business or industry changes driving this perspective?Read more
AN
US$13.2
58.4% undervalued intrinsic discount
Fair Value
Profit Margin
17.34%
Future PE
17.12x
Price in 2029
US$16.59
Radiation Free Breast Imaging And Regulatory Momentum Will Support Long Term Screening Adoption
Catalysts About QT Imaging Holdings QT Imaging Holdings develops radiation free, compression free 3D breast imaging systems paired with a cloud based software and analytics platform. What are the underlying business or industry changes driving this perspective?Read more
AN
US$11.6
52.7% undervalued intrinsic discount
Fair Value
Profit Margin
15.36%
Future PE
18.82x
Price in 2029
US$14.58
Slow Reimbursement And Costly SaaS Shift Will Ultimately Support Radiation Free Breast Imaging Adoption
Catalysts About QT Imaging Holdings QT Imaging Holdings develops radiation free, compression free 3D breast imaging systems and a cloud based software platform that extracts quantitative imaging biomarkers. What are the underlying business or industry changes driving this perspective?Read more
AN
US$10
45.1% undervalued intrinsic discount
Fair Value
Profit Margin
16.74%
Future PE
13.81x
Price in 2029
US$12.54
Trending Discussion
Recently Updated Narratives
AN
Radiation Free Breast Imaging And Regulatory Progress Will Support Powerful Long Term Upside
Fair Value: US$13.2 58.4% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Radiation Free Breast Imaging And Regulatory Momentum Will Support Long Term Screening Adoption
Fair Value: US$11.6 52.7% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Slow Reimbursement And Costly SaaS Shift Will Ultimately Support Radiation Free Breast Imaging Adoption
Fair Value: US$10 45.1% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
QT Imaging Holdings, Inc. Key Details
Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
- -1.11
- 41.68%
- -58.94%
- 138.3%
About QTI
- Founded
- 2012
- Employees
- 32
- CEO
- WebsiteView website
QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems with low frequency sound waves for detection, diagnosis, and treatment of diseases in the United States and Internationally. The company offers QT Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient’s breast. It serves patients, medical professionals, and radiologists. The company has a collaboration with Olea Medical S.A.S for the development of QTI Imaging-Olea Viewer; and a strategic partnership with Intelerad Medical Systems Incorporated. QT Imaging Holdings, Inc. was founded in 2012 and is headquartered in Novato, California.
